Showing 301 - 320 results of 367 for search '"Dexamethasone"', query time: 0.06s Refine Results
  1. 301

    Finding the Culprit: Cushing Syndrome Secondary to Lung Carcinoid Tumor by Richard Vaca, MD, Nirali A. Shah, MD

    Published 2025-01-01
    “…The ACTH and cortisol levels remained elevated after a low-dose dexamethasone suppression test. Magnetic resonance imaging of the pituitary gland did not reveal any adenoma and inferior petrosal sinus sampling showed no central-to-peripheral gradient. …”
    Get full text
    Article
  2. 302

    Quantitative Analysis of Retinal Microvascular Perfusion and Novel Biomarkers of the Treatment Response in Diabetic Macular Edema by Young Gun Park, Young-Hoon Park

    Published 2020-01-01
    “…We assessed the changes between the baseline microvascular parameters and final treatment response in patients with DME, initially treated with intravitreal dexamethasone (DEX) implant followed by antivascular endothelial growth factor (VEGF) injections on an as-needed basis. …”
    Get full text
    Article
  3. 303

    Ectopic ACTH Syndrome Emerging 5 Years after the Diagnosis of Neuroendocrine Tumor by Minghao Liu, Diane Hamele-Bena, John Ausiello, Gabrielle Page-Wilson

    Published 2019-01-01
    “…Serum cortisol was 61mcg/dL after an overnight 1mg dexamethasone suppression test (<1.8mcg/dL) and urinary free cortisol was 7544 mcg/24h (<45mcg/24h), establishing the diagnosis of Cushing’s syndrome. …”
    Get full text
    Article
  4. 304

    ENDOCRINE DISORDERS IN DOGS: EPIDEMIOLOGY, CLINICAL PRESENTATION, AND DIAGNOSTIC METHODS by Daniela Neagu, Vlad-Emil Luca, Răzvan Codea, Cristian Popovici, Anca Bărbos, Ștefania Dandea, Dragoș Hodor, Alexandra Biriș

    Published 2024-08-01
    “…Diagnostic methods included glucose monitoring, glycemic curve analysis, and low-dose dexamethasone suppression tests, with imaging (ultrasound) confirming endocrine gland involvement in 50% of Cushing's cases. …”
    Get full text
    Article
  5. 305

    Case report: Successful treatment of a thallium sulfate intoxication in a dog with use of Prussian blue by Fergal M. McDermott, Anne A. Kan, Claudine C. Hunault, Joris H. Robben, Dylan W. de Lange, Marieke A. Dijkman

    Published 2025-02-01
    “…Intervention involved supportive care with subcutaneous fluids, carprofen, butylscopolamine and dexamethasone in combination with targeted treatment using the chelating agent Prussian blue (15 days) followed by activated charcoal (4 days). …”
    Get full text
    Article
  6. 306

    Sustained response off treatment after fostamatinib in refractory immune thrombocytopenia: A series of four case reports by Waleed Ghanima, Francisco Javier Lucas Boronat, Valentina Carrai, Stefan Rackwitz

    Published 2025-12-01
    “…Before fostamatinib, he was unresponsive to high-dose dexamethasone, IVIG, eltrombopag and romiplostim. After 11 months of fostamatinib, his dose was tapered for three months and ultimately discontinued. …”
    Get full text
    Article
  7. 307

    Study of the effect of azithromycin on airway remodeling in asthma via the SAPK/JNK pathway by Dannv Ma, Huaqing Du, Yi Huang, Aiwu Pan, Lu Gan

    Published 2024-12-01
    “…Methods Simulated asthmatic AR mouse model was developed by induction with ovalbumin (OVA) and intervened with AZM or dexamethasone (DEX) and anisomycin (JNK activator). Pathological changes in mouse lung tissues and AR were assessed by HE and Masson staining. …”
    Get full text
    Article
  8. 308
  9. 309

    Review: cell mechanisms in the control of inflammatory foundations of obesity and secondary metabolic disorders by Kristin Goldstone, Keelin Irwin, Ava O' Meara-Cushen, Cathy Brougham

    Published 2024-12-01
    “…Wegovy) and glucocorticoids (e.g. dexamethasone). The complex clinical and regulatory history of these anti-obesity avenues has derived the investigation into alternative strategies utilising natural resources. …”
    Get full text
    Article
  10. 310

    Formulation for Muscle Building and Mobility Improvement by Bingbing CAO, Zhengdong LIU, Huan GE, Jiali ZHOU, Xingwang YE, Mingyuan QI, Renyan LIU, Yiqiao XU

    Published 2025-02-01
    “…A zebrafish larval model of dexamethasone-induced sarcopenia was used to evaluate the formula's influence on muscle tissue morphology, myelin sheath fluorescence intensity, and the expression of muscle atrophy-related genes. …”
    Get full text
    Article
  11. 311

    Use of Minimal Residual Disease Status to Reduce Uncertainty in Estimating Long-term Survival Outcomes for Newly Diagnosed Multiple Myeloma Patients by Naomi van Hest, Peter Morten, Keith Stubbs, Nicola Trevor

    Published 2023-01-01
    “…**Methods:** Standard and response-based PSMs, estimating patient life-years (LYs) over a lifetime horizon, were developed for NDMM patients treated with bortezomib, thalidomide, and dexamethasone (BTd) with or without daratumumab as induction and consolidation therapy. …”
    Get full text
    Article
  12. 312

    Differential Regulation of Gene Expression of Alveolar Epithelial Cell Markers in Human Lung Adenocarcinoma-Derived A549 Clones by Hiroshi Kondo, Keiko Miyoshi, Shoji Sakiyama, Akira Tangoku, Takafumi Noma

    Published 2015-01-01
    “…After treatment with dexamethasone (DEX), 8-bromoadenosine 3′5′-cyclic monophosphate (8-Br-cAMP), 3-isobutyl-1-methylxanthine (IBMX), and keratinocyte growth factor (KGF), surfactant protein B and TTF-1 expression levels were enhanced. …”
    Get full text
    Article
  13. 313

    Anti-diabetic effect of aloin via JNK-IRS1/PI3K pathways and regulation of gut microbiota by Ruting Zhong, Lanbin Chen, Yuanyuan Liu, Shouxia Xie, Sumei Li, Bin Liu, Chao Zhao

    Published 2022-01-01
    “…The insulin-resistant HepG2 (IR-HepG2) cell model and the type 2 diabetic (T2D) mouse model were successfully established using dexamethasone and a high-fat high-sucrose diet with low-dose streptozotocin, respectively. …”
    Get full text
    Article
  14. 314

    Analysis of Glucocorticoids as Potential Adulterants in Cosmetic Products: A Dual Approach for Qualitative and Quantitative Evaluation Based on ELISA and HPLC-MS Methods by Seyedeh Rojin Shariati Pour, Afsaneh Emamiamin, Martina Zangheri, Donato Calabria, Massimo Guardigli, Emanuele Porru, Jessica Fiori, Mara Mirasoli

    Published 2025-01-01
    “…First, a reversed-phase HPLC-MS method was optimized and fully validated in order to identify and quantify eight corticosteroids (methylprednisolone, beclomethasone, flunisolide, budesonide, betamethasone 17-valerate, beclomethasone dipropionate, flumethasone, and dexamethasone). This reference method was then compared with an enzyme-linked immunosorbent assay (ELISA). …”
    Get full text
    Article
  15. 315

    Nuclear Factor-Kappa B Activity Regulates Brain Expression of P-Glycoprotein in the Kainic Acid-Induced Seizure Rats by Nian Yu, Qing Di, Hao Liu, Yong Hu, Ying Jiang, Yu-kui Yan, Yan-fang Zhang, Ying-dong Zhang

    Published 2011-01-01
    “…Male SD rats were divided into saline control group (NS group), KA induced epilepsy group (EP group), and epilepsy group intervened with NF-κB inhibitor-pyrrolidine dithiocarbamate salt (PDTC group) or with dexamethasone (DEX group). No seizures were observed in the rats of NS group. …”
    Get full text
    Article
  16. 316

    Identification and Validation of the Pyroptosis-Related Hub Gene Signature and the Associated Regulation Axis in Diabetic Keratopathy by Yi Cui, Li Wang, Wentao Liang, Li Huang, Shuting Zhuang, Hong Shi, Nuo Xu, Jianzhang Hu

    Published 2024-01-01
    “…Finally, several small compounds including all-trans-retinoic acid, Chaihu Shugan San, dexamethasone, and resveratrol were suggested as potential therapies targeting these hub genes for DK. …”
    Get full text
    Article
  17. 317

    Inhibiting H3K27 Demethylases Downregulates CREB‐CREBBP, Overcoming Resistance in Relapsed Acute Lymphoblastic Leukemia by Juan Lazaro‐Navarro, Clara Alcon, Mathurin Dorel, Lina Alasfar, Lorenz Bastian, Claudia Baldus, Kathy Astrahantseff, Marie‐Laure Yaspo, Joan Montero, Cornelia Eckert

    Published 2025-01-01
    “…High CREBBP expression in BCP‐ALL cell lines correlated with high GSK‐J4 sensitivity and low dexamethasone sensitivity. GSK‐J4 treatment also induced Bcl‐2 and Bcl‐XL dependency and apoptosis. …”
    Get full text
    Article
  18. 318
  19. 319

    Anti-inflammatory Property of Galectin-1 in a Murine Model of Allergic Airway Inflammation by Yunxiang Lv, Mengyuan Dai, Muzi Wang, Fangfang Chen, Rongyu Liu

    Published 2019-01-01
    “…In the challenge phase, a subset of mice was treated intraperitoneally with recombinant Gal-1 (rGal-1) or dexamethasone (Dex). We found that rGal-1 inhibited pulmonary inflammatory cell recruitment, mucus secretion, bronchoalveolar lavage fluid (BALF) inflammatory cell infiltration, and cytokine production. …”
    Get full text
    Article
  20. 320

    Cell-Specific Regulation of Inflammatory Cytokines and Acute-Phase Proteins by the Glucocorticoid Receptor by Rebecca Winkler, Hong Lu

    Published 2023-01-01
    “…Primary human hepatocytes (PHH) were treated with combinations of tumor necrosis factor alpha (TNFα), lipopolysaccharide (LPS), and dexamethasone (DEX) for 24 h, following which chemokine mRNA and protein expression were analyzed using qPCR and enzyme-linked immunosorbent assay assays. …”
    Get full text
    Article